High seroreactivities to orthoebolaviruses in rural Cameroon: a case-control study on non-human primate bites and a cross-sectional survey in rural population

Archive ouverte

Ramassamy, Jill-Léa | Ayouba, Ahidjo | Thaurignac, Guillaume | Bilounga Ndongo, Chanceline | Nnuka, Patrick | Betsem, Edouard | Njouom, Richard | Mpoudi Ngole, Eitel | Vanhomwegen, Jessica | Hoinard, Damien | England, Patrick | Journeaux, Alexandra | Picard, Caroline | Thomas, Damien | Pannetier, Delphine | Baize, Sylvain | Delaporte, Eric | Peeters, Martine | Gessain, Antoine

Edité par CCSD ; Oxford University Press -

International audience. Background Ebola (EBOV) and Sudan (SUDV) orthoebolaviruses are responsible for lethal haemorrhagic fever outbreaks in humans in Central and West Africa, and in apes that can be at the source of human outbreaks for EBOV. Methods To assess the risk of exposure to orthoebolaviruses through contact with non-human primates (NHP), we tested the presence of antibodies against different viral proteins with a microsphere-based multiplex immunoassay in a case-control study on bites from NHPs in forest areas from Cameroon (n=795), and in cross-sectional surveys from other rural populations (n=622) of the same country. Results Seroreactivities against at least two viral proteins were detected in 13% and 12% of the samples for EBOV and SUDV, respectively. Probability of seroreactivity was not associated with history of NHP bites, but was three times higher in Pygmies compared to Bantus. Although no neutralizing antibodies to EBOV and SUDV were detected in a selected series of highly reactive samples, avidity results indicate strong affinity to SUDV antigens. Conclusion The detection of high level of seroreactivities against orthoebolaviruses in rural Cameroon where no outbreaks have been reported, raises the possibilities of silent circulation of orthoebolavirus, or of other not yet documented filoviruses, in these forested regions.

Suggestions

Du même auteur

Geographic distribution, clinical epidemiology and genetic diversity of the human oncogenic retrovirus HTLV-1 in Africa, the world’s largest endemic area

Archive ouverte | Gessain, Antoine, S | CCSD

International audience. The African continent is considered the largest high endemic area for the oncogenic retrovirus HTLV-1 with an estimated two to five million infected individuals. However, data on epidemiologi...

Epidemiological Evidence of Nosocomial and Zoonotic Transmission of Human T-Cell Leukemia Virus-1 in a Large Survey in a Rural Population of Central Africa

Archive ouverte | Ramassamy, Jill Léa | CCSD

International audience. BackgroundCentral Africa is one of the largest areas of high endemicity for human T-cell leukemia virus-1 (HTLV-1). However, no preventive measures are yet implemented to reduce its transmiss...

Adult T-cell leukemia/lymphoma incidence rate in French Guiana: a prospective cohort of women infected with HTLV-1

Archive ouverte | Ramassamy, Jill-Léa | CCSD

International audience. Adult T-cell leukemia/lymphoma (ATL) is an aggressive malignancy caused by the human T-cell leukemia virus type 1 (HTLV-1). The incidence of ATL among HTLV-1 carriers remains largely unknown ...

Chargement des enrichissements...